chr11-63406597-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_080866.3(SLC22A9):āc.1174C>Gā(p.Leu392Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_080866.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC22A9 | NM_080866.3 | c.1174C>G | p.Leu392Val | missense_variant | 7/10 | ENST00000279178.4 | |
SLC22A9 | XM_017017159.3 | c.1174C>G | p.Leu392Val | missense_variant | 7/8 | ||
SLC22A9 | XM_047426335.1 | c.481C>G | p.Leu161Val | missense_variant | 5/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC22A9 | ENST00000279178.4 | c.1174C>G | p.Leu392Val | missense_variant | 7/10 | 1 | NM_080866.3 | P1 | |
SLC22A9 | ENST00000536333.5 | c.*302C>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/7 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461598Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727088
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2021 | The c.1174C>G (p.L392V) alteration is located in exon 7 (coding exon 7) of the SLC22A9 gene. This alteration results from a C to G substitution at nucleotide position 1174, causing the leucine (L) at amino acid position 392 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.